Wednesday, October 4, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from AstraZeneca
Steering Committee Chair
Professor of Medicine
Director, Division of Nephrology
University of Maryland School of Medicine
Baltimore, Maryland
Steering Committee Member
Patrick A. Lehan Chair in
Cardiovascular Research
Professor of Medicine and Physiology
University of Mississippi
Jackson, Mississippi
Steering Committee Member
Professor of Medicine
University of Missouri, Kansas City
Saint Luke's Mid America Heart Institute
Kansas City, Missouri
Steering Committee Member
Professor of Medicine
UT Southwestern Medical Center
Dallas, Texas
Steering Committee Member
Professor of Clinical Medicine
Indiana University
Indianapolis, Indiana
Steering Committee Member
Fred Hatch Professor of Medicine
Director, Clinical Outcomes and Clinical Trials Program
Division of Neurology
University of Tennessee Health Science Center
Memphis, Tennessee
Steering Committee Chair
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie Inc.; AstraZeneca Pharmaceuticals, LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Boston Scientific; Janssen Pharmaceuticals; Merck Sharpe & Dohme; Relypsa, Inc.; Vifor Pharma
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Amgen Inc.; AstraZeneca Pharmaceuticals, LP; Bayer HealthCare; CVRx; G3 Pharmaceuticals; Janssen Pharmaceuticals; LivaNova; Luitpold Pharmaceuticals, Inc.; Medtronic; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Roche; Vifor
Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals, LP; Janssen Pharmaceuticals; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Amarin Corporation PLC; Amgen Inc.; AstraZeneca Pharmaceuticals LP; Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; Eisai Inc.; GlaxoSmithKline; Glytec; Intarcia Therapeutics, Inc.; Janssen Pharmaceuticals; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk A/S; Sanofi
Received grants for clinical research from: AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Amgen Inc.; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Bayer HealthCare; Novo Nordisk A/S; Quintiles; Reata Pharmaceuticals, Inc.; Relypsa, Inc.; ZS Pharma, Inc.
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Akebia; AstraZeneca Pharmaceuticals LP; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc.; Vifor Pharma
Served as a speaker or a member of a speakers bureau for: Keryx Biopharmaceuticals, Inc.; Pfizer Inc.
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP; Bayer; Cara Therapeutics; Tricida
